Cytomegalovirus gH Late Neutralizing Antigen antibody | HCMV16 (51C1)

100% Secure

Mouse anti Cytomegalovirus gH Late Neutralizing Antigen

Product Type
Monoclonal Antibody
Clone
HCMV16 (51C1)
Isotype
IgG1
Product CodeApplicationsDatasheetMSDSPack SizeList PriceQuantity
2470-5437 C E FN IF IP 0.2 mg
Mouse anti Cytomegalovirus gH Late Neutralizing Antigen antibody, clone HCMV16 (51C1) recognizes Cytomegalovirus glycoprotein H (gH) late neutralizing antigen and reacts with MRC-5 infected cells. Mouse anti Cytomegalovirus gH Late Neutralizing Antigen antibody, clone HCMV16 (51C1) does not react with HSV, VZV, EBV or uninfected cells.

Product Details

Target Species
Viral
Product Form
Purified IgG - liquid
Preparation
Purified IgG prepared by affinity chromatography on Protein A
Buffer Solution
Phosphate buffered saline
Preservative Stabilisers
0.09%Sodium Azide (NaN3)
Carrier Free
Yes
Immunogen
Cytomegalovirus extracts.
Approx. Protein Concentrations
1.0 mg/ml

Storage Information

Storage
Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
Shelf Life
18 months from date of despatch.

More Information

Regulatory
For research purposes only

Applications of Cytomegalovirus gH Late Neutralizing Antigen antibody

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Application Name Verified Min Dilution Max Dilution
ELISA
Functional Assays
Immunofluorescence
Immunohistology - Frozen
Immunoprecipitation
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using the appropriate negative/positive controls.

Product Specific References

References for Cytomegalovirus gH Late Neutralizing Antigen antibody

  1. Cranage, M.P. et al. (1988) Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.
    J Virol. 62 (4): 1416-22.
  2. Hamilton, A.A. et al. (1997) A humanized antibody against human cytomegalovirus (CMV) gpUL75 (gH) for prophylaxis or treatment of CMV infections.
    J Infect Dis. 176 (1): 59-68.
  3. Milne, R.S. et al. (1998) Human cytomegalovirus glycoprotein H/glycoprotein L complex modulates fusion-from-without.
    J Gen Virol. 79 ( Pt 4): 855-65.